Lisitril and hepatic neoplasm malignant Patient Reports February 10, 2012

Lisitril Side Effects Report #4867070-8
Lisitril side effect was reported by a Consumer or non-health professional from SWITZERLAND on Dec 08, 2005. Male patient, 75 years of age, was diagnosed with essential hypertension, dyspepsia, diabetes mellitus insulin-dependent, hyperlipidaemia, platelet aggregation inhibition and was treated with Lisitril. After drug was administered, patient experienced the following side effects: alcoholism , blood culture positive, condition aggravated, cytolytic hepatitis, duodenal ulcer, encephalopathy, hepatic failure, hepatic neoplasm malignant, hepatitis cholestatic. Lisitril dosage: 2.5 MILLIGRAM. During the same period patient was treated with NEXIUM, GLUCOPHAGE, SELIPRAN, ASPIRIN, EFFEXOR, TOREM, PRADIF, PROSCAR. Patient was hospitalized. Patient died.